Provided by Tiger Trade Technology Pte. Ltd.

Ecopetrol SA

17.40
-0.0600-0.34%
Volume:355.56K
Turnover:6.17M
Market Cap:35.77B
PE:9.14
High:17.49
Open:17.27
Low:17.22
Close:17.46
52wk High:18.38
52wk Low:8.57
Shares:2.06B
Float Shares:237.00M
Volume Ratio:0.78
T/O Rate:0.15%
Dividend:0.99
Dividend Rate:5.70%
EPS(TTM):1.90
EPS(LYR):1.16
ROE:15.95%
ROA:7.31%
PB:1.75
PE(LYR):14.94

Loading ...

Rhythm Pharmaceuticals Announces Preliminary Data from Phase 2 Trial that Showed RM-718 Demonstrated Positive Efficacy Signal in Acquired Hypothalamic Obesity

GlobeNewswire
·
Aug 04

Karyopharm down 69% after XPORT-EC-042 trial did not meet primary endpoint

TIPRANKS
·
Jul 31

Agios Reports Second Quarter 2026 Financial Results and Provides Business Update

GlobeNewswire
·
Jul 30

Press Release: Pharming Reports Second Quarter and First Half 2026 Financial Results and Revises Year-end Guidance; Strong Joenja Momentum and Near-term Clinical Readouts to Support Broader Therapeutic Use

Dow Jones
·
Jul 30

Incyte says EC approves Opzelura cream for treatment of AD

TIPRANKS
·
Jul 29

Earning Preview: Ecopetrol SA Q2 revenue is expected to increase by 39.77%, and institutional views are bullish

Earnings Agent
·
Jul 28

The EU’s 50bn alley-oop to BECCS projects in the Pulp & Paper industry

Fastmarkets
·
Jul 22

Rhythm Pharmaceuticals to Report Second Quarter 2026 Financial Results on Tuesday, August 4, 2026

GlobeNewswire
·
Jul 21

Press Release: Ecopetrol Resumes the Tender Offer in Brazil to Complete the Acquisition of a Controlling Equity Stake in Brava Energia S.A.

Dow Jones
·
Jul 21

Ecopetrol: No compromise to integrity of information from cybersecurity incident

TIPRANKS
·
Jul 21

Ecopetrol reports cybersecurity incident

TIPRANKS
·
Jul 19

Ecopetrol's Acquisition Appeal Backed by Brazilian Regulator, Reviving Takeover Process

Deep News
·
Jul 17

Press Release: Ecopetrol Reports CVM Decision on Appeal Related to the Tender Offer

Dow Jones
·
Jul 16

Ecopetrol SA (EC) Gets a Sell from Morgan Stanley

TIPRANKS
·
Jul 16

Over 600 Drugs Pass Preliminary Review for China's 2026 National Reimbursement Drug List

Stock News
·
Jul 14

Rhythm Pharmaceuticals Announces The New England Journal of Medicine Publication of Phase 3 TRANSCEND Trial Results in Acquired Hypothalamic Obesity

GlobeNewswire
·
Jul 09

Zoetis granted EC Marketing Authorization for Poulvac Procerta vaccine

TIPRANKS
·
Jul 07

Genmab Announces TEPKINLY® (epcoritamab) in Combination with Lenalidomide and Rituximab is Approved by the European Commission for the Treatment of Relapsed or Refractory Follicular Lymphoma

GlobeNewswire
·
Jul 07

AbbVie says Tepkinly combo approved by EC for lymphoma treatment

TIPRANKS
·
Jul 07

Novartis receives European Commission approval for Itvisma® for spinal muscular atrophy (SMA)

GlobeNewswire
·
Jul 02